Drug Shortage Report for ACT CIPROFLOXACIN

Last updated on 2021-11-25 History
Report ID 149931
Drug Identification Number 02247339
Brand name ACT CIPROFLOXACIN
Common or Proper name CIPROFLOXACIN 250MG FC TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CIPROFLOXACIN
Strength(s) 250MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-11-24
Estimated end date 2022-01-31
Actual end date
Shortage status Actual shortage
Updated date 2021-11-25
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2021-11-25 French Compare
v1 2021-11-25 English Compare